These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registry. Perez G, Rodriguez-Granillo AM, Mieres J, Llaurado C, Rubilar B, Risau G, Fernandez-Pereira C, Rodriguez AE. J Invasive Cardiol; 2009 Aug; 21(8):378-82. PubMed ID: 19652248 [Abstract] [Full Text] [Related]
24. Antiplatelet intervention in acute coronary syndrome. Arora RR, Rai F. Am J Ther; 2009 Aug; 16(5):e29-40. PubMed ID: 19092648 [Abstract] [Full Text] [Related]
25. Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry. Chiang FT, Shyu KG, Wu CJ, Mar GY, Hou CJ, Li AH, Wen MS, Lai WT, Lin SJ, Kuo CT, Kuo C, Li YH, Hwang JJ, ACS Full Spectrum Registry Investigators. J Formos Med Assoc; 2014 Nov; 113(11):794-802. PubMed ID: 24076272 [Abstract] [Full Text] [Related]
27. Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Dörler J, Edlinger M, Alber HF, Altenberger J, Benzer W, Grimm G, Huber K, Pachinger O, Schuchlenz H, Siostrzonek P, Zenker G, Weidinger F, Austrian Acute PCI Investigators. Eur Heart J; 2011 Dec; 32(23):2954-61. PubMed ID: 21920970 [Abstract] [Full Text] [Related]
28. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent. Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Jia de A, Cao Z, Nie B, Ge HL, Yang SW, Yan ZX. Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120 [Abstract] [Full Text] [Related]
29. The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Amad H, Yan AT, Yan RT, Huynh T, Gore JM, Montalescot G, DeYoung JP, Gallo R, Rose B, Steg PG, Goodman SG, Canadian Global Registry of Acute Coronary Events (GRACE) Investigators. Can J Cardiol; 2012 May; 28(1):48-53. PubMed ID: 22112683 [Abstract] [Full Text] [Related]
30. Clinical and prognostic implications of the initial response to aspirin in patients with acute coronary syndrome. Spectre G, Mosseri M, Abdelrahman NM, Briskin E, Bulut A, Loncar S, Varon D, Alcalai R. Am J Cardiol; 2011 Oct 15; 108(8):1112-8. PubMed ID: 21821226 [Abstract] [Full Text] [Related]
33. Killip classification in patients with acute coronary syndrome: insight from a multicenter registry. El-Menyar A, Zubaid M, AlMahmeed W, Sulaiman K, AlNabti A, Singh R, Al Suwaidi J. Am J Emerg Med; 2012 Jan 15; 30(1):97-103. PubMed ID: 21159479 [Abstract] [Full Text] [Related]
34. Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study. Han Y, Li Y, Wang S, Jing Q, Wang Z, Wang D, Shu Q, Tang X. Am Heart J; 2009 Apr 15; 157(4):733-9. PubMed ID: 19332203 [Abstract] [Full Text] [Related]
35. Dual antiplatelet agent failure: a new syndrome or clinical nonentity? Barnes GD, Li J, Kline-Rogers E, Vedre A, Armstrong DF, Froehlich JB, Eagle KA, Gurm HS. Am Heart J; 2007 Oct 15; 154(4):732-5. PubMed ID: 17893001 [Abstract] [Full Text] [Related]
36. Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Poloński L, Gasior M, Gierlotka M, Kalarus Z, Cieśliński A, Dubiel JS, Gil RJ, Ruzyłło W, Trusz-Gluza M, Zembala M, Opolski G. Kardiol Pol; 2007 Aug 15; 65(8):861-72; discussion 873-4. PubMed ID: 17853315 [Abstract] [Full Text] [Related]
37. Demographic, management practices and in-hospital outcomes of Thai Acute Coronary Syndrome Registry (TACSR): the difference from the Western world. Srimahachota S, Kanjanavanit R, Boonyaratavej S, Boonsom W, Veerakul G, Tresukosol D, TACSR Group. J Med Assoc Thai; 2007 Oct 15; 90 Suppl 1():1-11. PubMed ID: 18431881 [Abstract] [Full Text] [Related]
38. Dual antiplatelet drug resistance in patients with acute coronary syndrome. Guha S, Sardar P, Guha P, Roy S, Mookerjee S, Chakrabarti P, Deb PK, Chaudhuri U, Deb S, Karmakar R, Dasgupta AK, Lahiri P. Indian Heart J; 2009 Oct 15; 61(1):68-73. PubMed ID: 19729693 [Abstract] [Full Text] [Related]
39. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald E, TRITON-TIMI 38 Investigators. Am Heart J; 2006 Oct 15; 152(4):627-35. PubMed ID: 16996826 [Abstract] [Full Text] [Related]
40. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study. Savonitto S, Ambrosini V, Marzocchi A, Tolaro S, Petronio AS, Galassi AR, Bongo AS, Gaglione A, Bolognese L, IDEA Survey Investigators, Italian Society of Invasive Cardiology. Ital Heart J; 2005 Feb 15; 6(2):106-18. PubMed ID: 15819503 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]